Company Overview
Canopy Growth Corporation is a global diversified cannabis and hemp company, they have operations in over a dozen countries across five continents. Canopy Growth operates ten licensed cannabis production sites with over 4.4 million square feet of production capacity, including over 500,000 square feet of GMP certified production space. They are the first Canadian TSX and NYSE listed equity to invest in the controlling stake of an American Operator (Acreage Holdings).
[stock_market_chart symbol=”WEED.TO” range=”1y” settings='{“primaryChartType”:”smoothedLine”,”width”:”100%”,”height”:”350px”,”marginTop”:0,”marginBottom”:0,”marginLeft”:10,”marginRight”:10,”primaryPanelTitle”:”Price”,”secondaryPanelTitle”:”Volume”,”fontSize”:13,”color”:”#383838″,”primaryLineColor”:”#000″,”primaryLineColorAlpha”:0.15,”secondaryLineColor”:”#000″,”secondaryLineColorAlpha”:0.15,”backgroundColor”:”#fff”,”gridColor”:”#e0e0e0″,”gridAlpha”:0.8,”cursorColor”:”#ba0000″,”cursorAlpha”:0.8,”scrollbarBackgroundColor”:”#fff”,”scrollbarSelectedBackgroundColor”:”#000″,”scrollbarGraphFillColor”:”#000″,”scrollbarSelectedGraphFillColor”:”#000″,”primaryLineThickness”:0,”secondaryLineThickness”:0,”gridThickness”:0,”precision”:2,”thousandsSeparator”:”,”,”decimalSeparator”:”.”,”usePrefixes”:false,”mouseWheelZoomEnabled”:false,”cursorEnabled”:false,”exportEnabled”:false,”scrollbarEnabled”:false,”legendEnabled”:false,”periods”:”1W,1M,6M,YTD,1Y,ALL”,”defaultPeriod”:”1y”}’]
Key Share Information
| Current Share Price | $23.20 |
| Market Capitalization | $7,830.24 |
| Last Quarter (Share Data) | 3/31/2019 |
| Shares Outstanding (in Millions) | 337.51 |
| Options (in Millions) | 32.83 |
| Warrants (in Millions) | 107.85 |
| Fully Diluted Shares (in Millions) | 478.19 |
| Enterprise Value | $6,839.77 |
| TTM Revenue | $400.38 |
| TTM Growth Margin % | 27.32% |
| TTM Operating Expenses | $1,089.00 |
| TTM OCF | -$520.51 |
| P/S TTM | 19.56 |
| P/S (Last Quarter Run Rate) | 7.72 |
Key Balance Sheet Information (in Millions $CAD)
| CYQ4'16 Q3'16 | CYQ1'17 Q4'16 | CYQ2'17 Q1'17 | CYQ3'17 Q2'17 | CYQ4'17 Q3'17 | CYQ1'18 Q4'17 | CYQ2'18 Q1'18 | CYQ3'18 Q2'18 | CYQ4'18 Q3'18 | CYQ1'19 Q4'18 |
|
|---|---|---|---|---|---|---|---|---|---|---|
| Cash | $92.50 | $101.80 | $115.49 | $108.21 | $237.71 | $322.56 | $657.90 | $429.40 | $4,115.87 | $2,480.83 |
| Biological Assets | $5.31 | $14.73 | $9.28 | $23.50 | $15.08 | $16.35 | $52.81 | $20.72 | $31.01 | $78.98 |
| Inventory | $50.60 | $45.98 | $65.49 | $73.77 | $93.24 | $101.61 | $118.20 | $150.41 | $184.96 | $262.11 |
| Total Assets | $280.67 | $702.72 | $743.66 | $798.69 | $1,095.15 | $1,436.82 | $2,112.31 | $2,976.46 | $8,640.12 | $8,731.81 |
| Net Tangible Assets | $214.12 | $299.09 | $313.15 | $368.12 | $694.94 | $1,020.37 | $1,670.22 | $1,758.44 | $6,655.96 | $6,668.19 |
| Intangibles/Goodwill | $66.55 | $403.63 | $430.52 | $430.57 | $400.21 | $416.45 | $442.10 | $1,218.03 | $1,984.16 | $2,063.61 |
| Total Liabilities | $29.14 | $62.99 | $60.80 | $67.12 | $75.29 | $193.58 | $887.85 | $1,135.64 | $1,216.44 | $1,490.36 |
Key Operating Items (Quarterly in Millions $CAD)
| CYQ2'17 Q1'17 | CYQ3'17 Q2'17 | CYQ4'17 Q3'17 | CYQ1'18 Q4'17 | CYQ2'18 Q1'18 | CYQ3'18 Q2'18 | CYQ4'18 Q3'18 |
|
|---|---|---|---|---|---|---|---|
| Revenue | $15.87 | $17.57 | $21.70 | $77.95 | $25.92 | $23.33 | $97.70 |
| Change in Fair Value of Biologial Assets | -$21.67 | -$30.32 | -$29.73 | -$100.30 | -$57.29 | -$10.94 | -$22.27 |
| Gross Margin | $19.70 | $28.75 | $18.57 | $74.19 | $41.99 | -$33.98 | $12.45 |
| Marketing and Sales | $6.41 | $7.64 | $9.41 | $38.20 | $17.27 | $39.05 | $44.90 |
| Investor Relations | $0.64 | $0.77 | $0.80 | $3.84 | $3.14 | $14.54 | |
| Total Operating Expenses | $23.94 | $29.90 | $44.60 | $156.47 | $72.69 | $180.64 | $169.69 |
| Operating Cash Flow (Quarterly) | -$12.39 | -$10.48 | -$21.72 | -$36.91 | -$67.64 | -$130.50 | -$96.76 |
| Investing Cash Flow (Quarterly) | -$10.17 | -$23.69 | -$96.48 | -$93.24 | -$182.98 | -$193.07 | -$1,409.31 |
| Financing Cash Flow (Quarterly) | $36.26 | $26.88 | $247.70 | $215.01 | $585.96 | $95.07 | $5,088.88 |
*Investor Relations is the sum of “Investor Relations and Marketing and Promotion”
Financial Statements
Management Discussion
Listing Statement
All of the information on this dashboard was collected on a best efforts basis. This information should not be relied upon to make investment decisions. Always do your own diligence when purchasing a security and contact a licensed financial representative.